Low bone density and fractures before and after pediatric lung transplantation
- PMID: 29596964
- PMCID: PMC5931383
- DOI: 10.1016/j.bone.2018.03.021
Low bone density and fractures before and after pediatric lung transplantation
Abstract
Introduction: Children undergoing lung transplant are at risk for low bone mineral density (BMD) and fractures. The effect of lung transplantation on bone health in pediatric patients is unknown.
Materials and methods: We performed a retrospective chart review of all patients ages 2-21 years who underwent lung transplantation at our hospital from January 2000 to January 2015.
Results: 51 patients were studied. At the time of transplant evaluation, BMD Z-score was -2.2 ± 1.4, and 59% of patients had low BMD. BMD Z-score declined in the first year after treatment and returned to near-baseline by the third post-transplant year. Fractures occurred in 9 patients (18%) before and 15 patients (29%) after transplant. Bisphosphonate use was associated with improvement in BMD Z-score and lower mortality risk.
Conclusions: Pediatric patients had a high prevalence of low BMD at the time of lung transplant evaluation. BMD Z-scores declined in the year after transplant and returned to the pre-transplant level by the third post-transplant year while remaining below normal levels. Fractures were common at sites associated with significant morbidity. These findings support efforts to optimize bone health before and after pediatric lung transplantation, and future studies are needed to evaluate the role of bisphosphonates in these patients.
Keywords: Bisphosphonate; Bone mineral density; Fracture; Lung transplantation; Pediatric.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures


Similar articles
-
Prevention of bone loss and fracture after lung transplantation: a pilot study.Transplantation. 2001 Oct 15;72(7):1251-5. doi: 10.1097/00007890-200110150-00012. Transplantation. 2001. PMID: 11602851 Clinical Trial.
-
Bone health outcomes in post-lung transplant patients with cystic fibrosis.J Cyst Fibros. 2023 May;22(3):381-387. doi: 10.1016/j.jcf.2023.01.003. Epub 2023 Jan 18. J Cyst Fibros. 2023. PMID: 36669961
-
Increased risk of mortality in lung transplant patients with fragility fractures.Arch Osteoporos. 2025 Feb 5;20(1):19. doi: 10.1007/s11657-025-01502-x. Arch Osteoporos. 2025. PMID: 39907927
-
Lung transplantation and bone health: A narrative review.J Heart Lung Transplant. 2025 Jun;44(6):849-857. doi: 10.1016/j.healun.2025.01.010. Epub 2025 Jan 19. J Heart Lung Transplant. 2025. PMID: 39837402 Review.
-
Evaluation and management of bone disease and fractures post transplant.Transplant Rev (Orlando). 2008 Jan;22(1):52-61. doi: 10.1016/j.trre.2007.09.001. Transplant Rev (Orlando). 2008. PMID: 18631858 Review.
Cited by
-
Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients-A Systematic Review.J Clin Med. 2023 Feb 10;12(4):1416. doi: 10.3390/jcm12041416. J Clin Med. 2023. PMID: 36835951 Free PMC article. Review.
References
-
- Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996;101(3):262–9. - PubMed
-
- Maalouf NM, Shane E. Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab. 2005;90(4):2456–65. - PubMed
-
- Spira A, Gutierrez C, Chaparro C, Hutcheon MA, Chan CK. Osteoporosis and lung transplantation: a prospective study. Chest. 2000;117(2):476–81. - PubMed
-
- Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab. 1997;82(5):1497–506. - PubMed
-
- Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinology and metabolism clinics of North America. 2007;36(4):937–63. viii. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical